MedPath

Effects of SGLT2 inhibitors on appetite in patients with type 2 diabetes

Not Applicable
Conditions
type 2 diabetes
Registration Number
JPRN-jRCT1050220190
Lead Sponsor
in Kazuko
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
58
Inclusion Criteria

1) Those with a diagnosis of type 2 diabetes
2) Persons starting SGLT2 inhibitors
3) Patients between 20 and 85 years of age
4) Patients with renal function eGFR 30 or higher
5) BMI of 18.5 or more

Exclusion Criteria

1) Those undergoing treatment for cancer
2) Pregnant women
3) Those who are emotionally unstable due to mental illness, etc. and have difficulty participating in the research
4) Those who have difficulty in reading and understanding Japanese
5) Persons with dementia
6) Those who are judged by the attending physician or researcher to be unable to participate in the research.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath